Total Funding
71
46
Total FundingSeries D raised
Growth Score
-2 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
25984
Moximed develops innovative therapies for patients with knee osteoarthritis.
Josh Makower: Founder & ChairmanPast Role: Acclarent, Founder & Chairman- James Leech: Chief Financial and Strategy OfficerPast Role: Palette Life Sciences, VP of Strategy & Corporate Development
About the Company
Moximed focuses on enhancing care for patients suffering from osteoarthritis, particularly through the MISHA Knee System. This system offers an outpatient treatment option for those who have not found relief from other therapies and are not candidates for knee replacement. The company aims to improve patients' quality of life by addressing
their specific needs and challenges.
